The bank is opening 50 new branches in Philadelphia, Delaware and southern New Jersey over the next five years. » Read More
By: Lorie Konish
Going back to school in retirement can help you pick up new skills and new friends. Here's how to do it without breaking the bank. » Read More
By: Alex Sherman
Comcast expects Disney will let go of its 39 percent stake, giving CEO Brian Roberts complete ownership of the TV distributor and owner of content, according to people familiar with the matter. » Read More
By: Darla Mercado
The idea of investing in the next tech giant while it's still in its early stages is an attractive one — and it could cost you your life savings if you don't do it right. Here's what you should know about private offerings. » Read More
Jefferies raises its price target for AMD shares, predicting big market share gains for the chipmaker due to Intel's processor shortages.
Shares of the Shanghai-based Tesla rival have surged since debuting in the public market last week. But some investors are cautious, noting the stock has fallen from its post-IPO high.
Canada's legalization of recreational marijuana-use next month is not going to produce the 'high' that investors think, CNBC's Jim Cramer warns.
Nike shares just sprinted to an all-time high, and some market watchers foresee even bigger gains.
Many people tend to underestimate the complexity of Medicare and all the available options.
UBS raises its rating of AT&T to buy from neutral, citing "an overly negative outlook" and saying it expects a turnaround in operating performance.
Analysts are concerned the negative impact from Intel's processor manufacturing issues may last longer than one quarter.
CEO Tim Sloan informs Wells Fargo employees that as many as 26,500 positions will be eliminated.
The S&P 500 has a big problem: too much return from a handful of technology stocks. It has a plan to fix that, which goes into effect Monday, when Facebook, Alphabet and Netflix are on the move within S&P sectors, with big implications for investors.
Jim Cramer details what the rotation out of growth and into value means for the bull market.
Jim Cramer flies through his take on callers' favorite stocks, including a high-profile social media play.
Jim Cramer sits down with Yuval Cohen, the CEO of a company that is creating treatments derived from manmade cannabinoids for rare diseases like cystic fibrosis.
Jim Cramer doubles down on his warning about investing in marijuana stocks like Tilray, which has been trading wildly since CEO Brendan Kennedy's appearance on "Mad Money."
Jim Cramer points to the action in retail stocks as a sign that the economic windfall from the U.S.-China trade spat won't affect U.S. consumers as much as people think.
There may be a technical reason for the magnitude of the rally in Canadian pot producer Tilray, which has captured the attention of traders everywhere: It's too expensive to bet against the stock.
Wells Fargo is lowering its employee headcount by 5 to 10 percent in the next three years, the company announced Thursday.
If you're gearing up to enroll in Medicare for the first time, make sure you don't forget to evaluate Medigap insurance. This supplemental coverage can help you defray additional expenses. Here's what you should know.
The U.S. and China fired their latest billion-dollar shots in the escalating trade war this week. One market watcher is ready to declare a winner.
"As the market goes into full phase, all the hedge funds and everyone else who were short on anticipation might jump on here," the Wharton professor says.
Morgan Stanley reiterates its overweight rating for Amazon shares, saying customer data from its brick and mortar stores will lead to more sales.